TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31742366

Group type: EXPERIMENTAL
Intervention: High intensity laser therapy (HILT) with a power of 1.6 W and low fluence of 8 J/cm2
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Exercise-only control group
Number of subjects: 98
Study: 31282081

Group type: EXPERIMENTAL
Intervention: 14-day therapy with levofloxacin (750 mg), clarithromycin-MR (1 g), rabeprazole (60 mg), and bismuth subsalicylate (1,048 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 7-day therapy with levofloxacin (750 mg), clarithromycin-MR (1 g), rabeprazole (60 mg), and bismuth subsalicylate (1,048 mg)
Number of subjects: 100
Study: 28360432

Group type: EXPERIMENTAL
Intervention: 225 min per week of aerobic exercise (ALPHA trial)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 150 min per week of aerobic exercise (BETA trial)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 300 min per week of aerobic exercise (BETA trial)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Increases in VO2peak
Number of subjects: 360
Study: 25633037

Group type: EXPERIMENTAL
Intervention: Home mailing of self-sampler
Number of subjects: 14041

Group type: EXPERIMENTAL
Intervention: Picking up self-sampler at pharmacy
Number of subjects: 14041

Group type: COMPARATOR
Intervention: Standard reminder letter (control)
Number of subjects: 14041
Study: 24283282

Group type: EXPERIMENTAL
Intervention: 1,426 ppm fluoride toothpaste
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1,000 ppm fluoride toothpaste
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 ppm fluoride toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 ppm fluoride toothpaste (placebo)
Number of subjects: 0
Study: 20614474

Group type: EXPERIMENTAL
Intervention: Calcium carbonate 1200 mg daily
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1460
Study: 19841844

Group type: EXPERIMENTAL
Intervention: Function-centred inpatient treatment
Number of subjects: 174

Group type: COMPARATOR
Intervention: Pain-centred inpatient treatment
Number of subjects: 174
Study: 18163016

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 206

Group type: COMPARATOR
Intervention: Heparin and at least 4 weeks of oral anticoagulation therapy (OAT)
Number of subjects: 206
Study: 14979817

Group type: EXPERIMENTAL
Intervention: Narrative comprehension with varying temporal distances between events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal distance varied in terms of the duration of an intervening event
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal distance varied in terms of a temporal shift
Number of subjects: 0
Study: 11820234

Group type: EXPERIMENTAL
Intervention: Visual art dialogues
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control group (no visual art dialogues)
Number of subjects: 267
Study: 9516063

Group type: COMPARATOR
Intervention: Galanin infusion (8 microg/Kg/h) in healthy volunteers (group I)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Galanin infusion (8 microg/Kg/h) in cured acromegaly patients (group III)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Galanin infusion (8 microg/Kg/h) in patients with active acromegaly (group II)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of AUC in groups I and III vs group II
Number of subjects: 19
Study: 8034992

Group type: EXPERIMENTAL
Intervention: Dirithromycin, 500 mg once daily
Number of subjects: 591

Group type: COMPARATOR
Intervention: Erythromycin, 250 mg four times daily
Number of subjects: 591
Study: 29522927

Group type: EXPERIMENTAL
Intervention: Expand Your Horizon (three online body functionality writing exercises)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 261
Study: 29901376

Group type: EXPERIMENTAL
Intervention: Laughing training program for 3 days a week, 1 hour a day for 8 consecutive weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Laughing training program
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (resting in the same room)
Number of subjects: 38
Study: 23947316

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention delivering self-management training through 36 home visits over 2 years
Number of subjects: 144

Group type: COMPARATOR
Intervention: Bilingual control newsletter delivering the same information on the same schedule
Number of subjects: 144
Study: 21743037

Group type: EXPERIMENTAL
Intervention: Inductive reasoning training intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 20019638

Group type: EXPERIMENTAL
Intervention: Resistance training (n = 65), 8 core exercises, 2 sets of 8 repetitions at 70%-80% of one-repetition maximum, 3 times weekly
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Resistance training (n = 65)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Lowest tertile of SQ (2.5% attendance)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Highest tertile of SQ (64% attendance)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (25 true controls)
Number of subjects: 122
Study: 18978250

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (five sessions of individual and family counseling within 3 months of enrollment and continuous availability of ad hoc telephone counseling)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Drug treatment alone (donepezil prescribed for all patients)
Number of subjects: 158
Study: 16413875

Group type: EXPERIMENTAL
Intervention: BMSC transfer
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 67
Study: 12759327

Group type: EXPERIMENTAL
Intervention: Composite primary outcome measures
Number of subjects: 300276
Study: 11272956

Group type: EXPERIMENTAL
Intervention: Electronic checklist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 0
Study: 8871425

Group type: EXPERIMENTAL
Intervention: Stress inoculation training (SIT) and physical therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physical therapy only
Number of subjects: 60
Study: 1516292

Group type: EXPERIMENTAL
Intervention: High protein diet (mean 27% of energy as protein)
Number of subjects: 5
Study: 6419263

Group type: EXPERIMENTAL
Intervention: Plasma haloperidol levels (4.2‐11.0 ng/ml) during the first 14 days of treatment
Number of subjects: 14
Study: 29727758

Group type: EXPERIMENTAL
Intervention: Deliberate practice (n=10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Self-guided practice (n=8)
Number of subjects: 18
Study: 27036077

Group type: EXPERIMENTAL
Intervention: Percutaneous access
Number of subjects: 1416

Group type: COMPARATOR
Intervention: Surgical access
Number of subjects: 1416

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1416
Study: 24118113

Group type: EXPERIMENTAL
Intervention: Twice-daily biphasic insulin analogue (biphasic insulin aspart 70/30, biphasic insulin aspart 30)
Number of subjects: 100
Study: 23176984

Group type: EXPERIMENTAL
Intervention: Intrathecal 4 mg bupivacaine 0.5% + 25 μg fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal 50 mg prilocaine 2% + 25 μg fentanyl
Number of subjects: 60
Study: 21214129

Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2%-benzoyl peroxide 2.5% gel
Number of subjects: 2813

Group type: COMPARATOR
Intervention: Individual active ingredients and vehicle
Number of subjects: 2813
Study: 19189678

Group type: EXPERIMENTAL
Intervention: Thick smear layer with different dentin conditioners
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thin smear layer with different dentin conditioners
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dentin conditioners used prior to glass-ionomer adhesive application
Number of subjects: 50
Study: 16351670

Group type: EXPERIMENTAL
Intervention: Ibutilide (1 mg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Propafenone (70 mg)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ibutilide
Number of subjects: 82

Group type: COMPARATOR
Intervention: Propafenone
Number of subjects: 82
Study: 12361104

Group type: EXPERIMENTAL
Intervention: 20 mL ipecac syrup
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 mL ipecac syrup
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both doses of ipecac syrup
Number of subjects: 12
Study: 10603720

Group type: EXPERIMENTAL
Intervention: Ballpoint pen test (BPT) for sensory function
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Graded Semmes Weinstein monofilament test (SWM) for sensory function
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Voluntary muscle testing (VMT) for motor function
Number of subjects: 53
Study: 7857870

Group type: EXPERIMENTAL
Intervention: 19-acetylenic androstenedione (Plomestane)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 18-acetylenic deoxycorticosterone
Number of subjects: 0
Study: 1941408

Group type: EXPERIMENTAL
Intervention: Oatmeal alone (OM)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oatmeal-sucrose (OMS)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oatmeal-protein (OMP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oatmeal with protein and sucrose (OMPS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oatmeal (OM) and Oatmeal-sucrose (OMS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oatmeal-protein (OMP) and Oatmeal with protein and sucrose (OMPS)
Number of subjects: 8
Study: 7123952

Group type: EXPERIMENTAL
Intervention: Beta-methyl-digoxin (BMD) 0.5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digoxin 0.75 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Beta-methyl-digoxin (BMD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 30
Study: 30983518

Group type: EXPERIMENTAL
Intervention: Vicarious-affirmation through a fictional story
Number of subjects: 832

Group type: COMPARATOR
Intervention: Traditional self-affirmation (not explicitly detailed in the abstract)
Number of subjects: 832
Study: 29695706

Group type: EXPERIMENTAL
Intervention: LEI + MR
Number of subjects: 110

Group type: COMPARATOR
Intervention: LEI
Number of subjects: 110
Study: 27600897

Group type: EXPERIMENTAL
Intervention: Prolatan (latanoprost 0.005%) once daily in the evening
Number of subjects: 35

Group type: COMPARATOR
Intervention: Xalatan (latanoprost 0.005%) once daily in the evening
Number of subjects: 35
Study: 24854807

Group type: EXPERIMENTAL
Intervention: Flexible cognitive restraint during the weight loss intervention
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Flexible restraint increase during the WLM intervention
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Reduction of rigid restraint during the follow-up period
Number of subjects: 49
Study: 22776980

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: B. lactis with Lactobacillus rhamnosus GG
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 20032239

Group type: EXPERIMENTAL
Intervention: Platform dropped (8 cm, 0.9 g acceleration)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Platform held at small inclination (up to +/-3 degrees)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Platform dropped
Number of subjects: 19

Group type: COMPARATOR
Intervention: Platform held at small inclination
Number of subjects: 19
Study: 18534330

Group type: EXPERIMENTAL
Intervention: Swedish-style massage therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Light-touch bodywork control
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 44
Study: 16014203

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Adjusted indirect comparison method
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Naive method
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Direct evidence from RCTs
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Indirect comparisons
Number of subjects: 327
Study: 14512129

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 80 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dose proportionality
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 to 80 mg)
Number of subjects: 18
Study: 11028253

Group type: EXPERIMENTAL
Intervention: 18 mg methylphenidate HCl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 36 mg methylphenidate HCl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 54 mg methylphenidate HCl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All doses of methylphenidate HCl
Number of subjects: 0
Study: 9188114

Group type: EXPERIMENTAL
Intervention: Acetaminophen 15 mg.kg‐1
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ketorolac 1 mg.kg‐1
Number of subjects: 132
Study: 8195852

Group type: EXPERIMENTAL
Intervention: Brodimoprim, 400 mg loading dose followed by 200 mg daily for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Doxycycline, 200 mg loading dose followed by 100 mg daily for 10 days
Number of subjects: 60
Study: 3522770

Group type: EXPERIMENTAL
Intervention: Single initial 1500 mg dose of rifampin plus daily doses of 100 mg of dapsone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Weekly doses of 900 mg of rifampin plus daily doses of 100 mg of dapsone
Number of subjects: 15
Study: 29672747

Group type: EXPERIMENTAL
Intervention: Financial stress for UIA
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Chronic perceived stress at home (previous year) for UIA
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Chronic perceived stress at home (previous year) for ASAH
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Lifelong exposure to stress for UIA
Number of subjects: 1492

Group type: EXPERIMENTAL
Intervention: Lifelong exposure to stress for ASAH
Number of subjects: 1492
Study: 29694504

Group type: EXPERIMENTAL
Intervention: 5 cmH2O EPAP
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-EPAP
Number of subjects: 15
Study: 27160957

Group type: EXPERIMENTAL
Intervention: l-Citrulline (6 g/d) for 14 d
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 24527505

Group type: EXPERIMENTAL
Intervention: Impella
Number of subjects: 427

Group type: COMPARATOR
Intervention: IABP
Number of subjects: 427
Study: 22914710

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) testing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional coagulation analyses
Number of subjects: 100
Study: 20362677

Group type: EXPERIMENTAL
Intervention: Hierarchical method for smoothing in cortical thickness analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional procedures for smoothing in cortical thickness analysis
Number of subjects: 0
Study: 18047609

Group type: EXPERIMENTAL
Intervention: Kinetin 0.03% plus niacinamide 4%
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Niacinamide 4%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 16040442

Group type: EXPERIMENTAL
Intervention: Ultrasonic insertion of standardized class I inlays using high viscosity composite resin material (Tetric Ceram)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual insertion of standardized class I inlays using high viscosity composite resin material (Tetric Ceram)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasonic insertion of high and medium viscosity composite resin materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual insertion of high viscosity composite resin material
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasonic insertion of three composite resin materials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of filler distribution
Number of subjects: 0
Study: 12171842

Group type: EXPERIMENTAL
Intervention: 2 mg/kg daily oral corticosteroids
Number of subjects: 86

Group type: COMPARATOR
Intervention: 1 mg/kg daily oral corticosteroids
Number of subjects: 86
Study: 10404930

Group type: EXPERIMENTAL
Intervention: Gradual withdrawal of psychotropic medication
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 93

Group type: COMPARATOR
Intervention: Continuing to take psychotropic medication
Number of subjects: 93

Group type: COMPARATOR
Intervention: No exercise program
Number of subjects: 93
Study: 7750285

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) containing low doses of oestrogens and progestogens (Triquilar, Trinovum or Cilest)
Number of subjects: 87
Study: 2147600

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Clonidine + GHRH
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH(1‐29)‐NH2
Number of subjects: 6
Study: 7032184

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% eye drops
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol 3.0% eye drops
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study: 31053134

Group type: EXPERIMENTAL
Intervention: Weekly incremental reductions in oral corticosteroid (OCS) dose
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Reduction of daily OCS dose by 5 mg/day
Number of subjects: 135
Study: 28085986

Group type: EXPERIMENTAL
Intervention: Prefabricated glass fiber posts
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Custom-made glass fiber posts
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Composite cores without posts
Number of subjects: 143

Group type: COMPARATOR
Intervention: Gold alloy-based wrought posts and cast cores
Number of subjects: 143
Study: 25531289

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Entire study population
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Low-fat diet with energy expenditure adjustment
Number of subjects: 231

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 231
Study: 23669821

Group type: EXPERIMENTAL
Intervention: COMBINED training
Number of subjects: 28

Group type: COMPARATOR
Intervention: PLYO training
Number of subjects: 28
Study: 22293680

Group type: EXPERIMENTAL
Intervention: Low-dose caffeine (200 mg total from 2 pieces of chewing gum) administered at 3 different time points (‐35, ‐5, and +15 minutes) during cycling exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo administered at the other 2 points and at all 3 points in the control trial
Number of subjects: 8
Study: 20216490

Group type: EXPERIMENTAL
Intervention: Ultrasound irradiation administered to the pressure ulcer through the same dressing used in standard treatment (pulsed ultrasound, 20% duty cycle, 0.5W/cm2, 1MHz or 3MHz, for 10 minutes, five times weekly)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sham ultrasound
Number of subjects: 5
Study: 17545341

Group type: EXPERIMENTAL
Intervention: Intervention package comprising intense education, a range of reporting options, changes in report management and enhanced feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention package
Number of subjects: 0
Study: 15767639

Group type: EXPERIMENTAL
Intervention: Warfarin 1 mg daily
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 12077008

Group type: EXPERIMENTAL
Intervention: Asperger's syndrome
Number of subjects: 21

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 21
Study: 9822184

Group type: EXPERIMENTAL
Intervention: Esmolol (ultra-short acting beta-blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardioplegic arrest
Number of subjects: 0
Study: 7840071

Group type: EXPERIMENTAL
Intervention: High-amylose starch
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard starch (70% amylopectin, 30% amylose)
Number of subjects: 24
Study: 2375292

Group type: EXPERIMENTAL
Intervention: iopanoic acid
Number of subjects: 8

Group type: COMPARATOR
Intervention: underfeeding alone (UF)
Number of subjects: 8
Study: 6958476

Group type: EXPERIMENTAL
Intervention: Corticosteroids and beta 2-adrenergic agonist terbutaline (Group 2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Corticosteroids (Group 1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Beta 2-adrenergic agonist alone (additional group of 7 patients)
Number of subjects: 14
Study: 31775297

Group type: EXPERIMENTAL
Intervention: iCBT
Number of subjects: 151
Study: 28498374

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 30

Group type: COMPARATOR
Intervention: Subconjunctival saline (control)
Number of subjects: 30
Study: 26489050

Group type: EXPERIMENTAL
Intervention: Peristaltic external pneumatic compression (EPC) for 30 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study: 23326171

Group type: EXPERIMENTAL
Intervention: Double-guidewire technique (DGT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Transpancreatic precut sphincterotomy (TPS)
Number of subjects: 71
Study: 21791902

Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 10662

Group type: COMPARATOR
Intervention: Letters
Number of subjects: 10662
Study: 19745642

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20069077

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day plus aspirin 81 mg/day
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo plus aspirin 81 mg/day
Number of subjects: 181
Study: 16099343

Group type: EXPERIMENTAL
Intervention: Children attending day-care centers (DCC)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Public DCC
Number of subjects: 152

Group type: COMPARATOR
Intervention: Private DCC
Number of subjects: 152

Group type: COMPARATOR
Intervention: Demographic features
Number of subjects: 152